Showing results (181-190 of 228) with videos related to

Sort By:
Pageof 23
The Journal of Urology|July 21, 2010
Smaller prostate size predicts high grade prostate cancer at final pathologyMark R Newton, Sharon Phillips, Sam S Chang, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
World Journal of Urology|August 15, 2018
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancerMario I Fernández, Maurizio Brausi, Peter E Clark, et al.
The Journal of Urology|September 25, 2012
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experienceSamuel D Kaffenberger, Kirk A Keegan, Neil K Bansal, et al.
American Journal of Human Genetics|March 4, 2014
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibilityJoan P Breyer, Daniel C Dorset, Travis A Clark, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology|September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART IIWilliam T Lowrance, Rodney H Breau, Roger Chou, et al.
BJU International|May 31, 2019
Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal functionAndrew G McIntosh, Daniel C Parker, Brian L Egleston, et al.
Clinical Genitourinary Cancer|July 16, 2019
Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical ProstatectomySamuel A Weprin, Daniel C Parker, Joshua D Jones, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 21, 2017
Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progressionDing Xia, Doan V Lai, Weijuan Wu, et al.
Pageof 23